Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bolger

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of actionK W Gee, M B Bolger, R E Brinton, et al.
The Journal of Biological Chemistry|May 18, 1999
The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoformS J Yarwood, M R Steele, G Scotland, et al.
Pharmaceutical Research|August 18, 2009
Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporterLiya Xu, Ian S Haworth, Ashutosh A Kulkarni, et al.
The Journal of Biological Chemistry|May 29, 2000
ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regionsS J MacKenzie, G S Baillie, I McPhee, et al.
Analytical and Bioanalytical Chemistry|February 24, 2005
Calibration of NO sensors for in-vivo voltammetry: laboratory synthesis of NO and the use of UV-visible spectroscopy for determining stock concentrationsFinbar O Brown, Niall J Finnerty, Fiachra B Bolger, et al.
Immunological Investigations|December 1, 1985
Preparation and characterization of antisera and monoclonal antibodies to haloperidolM B Bolger, K Flurkey, R D Simmons, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 1. Evaluation and Adaptation of GastroPlus To Predict Bioavailability of Medchem SeriesPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
Pharmaceutical Research|October 22, 2010
Predicting the effect of fed-state intestinal contents on drug dissolutionEce Dilber Gamsiz, Mukul Ashtikar, John Crison, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 2. Rational Bioavailability Design by Global Sensitivity Analysis To Identify Properties Affecting BioavailabilityPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
BMC Neuroscience|December 4, 2017
Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampusSusan L Campbell, Thomas van Groen, Inga Kadish, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of actionK W Gee, M B Bolger, R E Brinton, et al.
The Journal of Biological Chemistry|May 18, 1999
The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoformS J Yarwood, M R Steele, G Scotland, et al.
Pharmaceutical Research|August 18, 2009
Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporterLiya Xu, Ian S Haworth, Ashutosh A Kulkarni, et al.
The Journal of Biological Chemistry|May 29, 2000
ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regionsS J MacKenzie, G S Baillie, I McPhee, et al.
Analytical and Bioanalytical Chemistry|February 24, 2005
Calibration of NO sensors for in-vivo voltammetry: laboratory synthesis of NO and the use of UV-visible spectroscopy for determining stock concentrationsFinbar O Brown, Niall J Finnerty, Fiachra B Bolger, et al.
Immunological Investigations|December 1, 1985
Preparation and characterization of antisera and monoclonal antibodies to haloperidolM B Bolger, K Flurkey, R D Simmons, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 1. Evaluation and Adaptation of GastroPlus To Predict Bioavailability of Medchem SeriesPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
Pharmaceutical Research|October 22, 2010
Predicting the effect of fed-state intestinal contents on drug dissolutionEce Dilber Gamsiz, Mukul Ashtikar, John Crison, et al.
Molecular Pharmaceutics|January 17, 2018
Physiologically Based Pharmacokinetic Modeling in Lead Optimization. 2. Rational Bioavailability Design by Global Sensitivity Analysis To Identify Properties Affecting BioavailabilityPankaj R Daga, Michael B Bolger, Ian S Haworth, et al.
BMC Neuroscience|December 4, 2017
Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampusSusan L Campbell, Thomas van Groen, Inga Kadish, et al.
Pageof 14